News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Endo Pharmaceuticals (ENDP) and Penwest Pharmaceutical (PPCO) Enter Into Agreement with Barr Pharmaceuticals, Inc. (BRL) to Settle Patent Litigation Over Opana(R) ER



4/13/2010 9:47:03 AM

CHADDS FORD, Pa., April 13 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals and Penwest Pharmaceuticals announced today that the companies have settled litigation with Barr Laboratories, Inc. regarding the production and sale of generic formulations of Opana(R) ER (oxymorphone hydrochloride) Extended Release Tablets CII.

About Endo

Forward Looking Statement

Endo Pharmaceuticals




Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES